respiratory
holy grail

Sandra Hodge answers the Holy Grail


This week we feature Sandra Hodge from Adelaide and her quest to develop novel ‘steroid-sparing’ therapies for chronic inflammatory lung diseases.  What’s the issue your research is trying to solve? New and effective macrophage-targeted therapies for chronic lung diseases What have you discovered so far? Pulmonary macrophage dysfunction that can lead to chronic airways inflammation in ...

Already a member?

Login to keep reading.


OR
© 2019 the limbic